Vaccines (Mar 2023)

Susceptibility of Diabetic Patients to COVID-19 Infections: Clinico-Hematological and Complications Analysis

  • Banan Atwah,
  • Mohammad Shahid Iqbal,
  • Saeed Kabrah,
  • Ahmed Kabrah,
  • Saad Alghamdi,
  • Aisha Tabassum,
  • Mohammed A. Baghdadi,
  • Hissah Alzahrani

DOI
https://doi.org/10.3390/vaccines11030561
Journal volume & issue
Vol. 11, no. 3
p. 561

Abstract

Read online

Background: Coronavirus disease 2019 has become a global health threat resulting in a catastrophic spread and more than 3.8 million deaths worldwide. It has been suggested that there is a negative influence of diabetes mellites (DM), which is a complex chronic disease, on COVID-19 severe outcomes. Other factors in diabetic patients may also contribute to COVID-19 disease outcomes, such as older age, obesity, hyperglycaemia, hypertension, and other chronic conditions. Methods: A cohort study was conducted on the demographics, clinical information, and laboratory findings of the hospitalised COVID-19 with DM and non-DM patients were obtained from the medical records in King Faisal Specialist Hospital and Research Centre, Saudi Arabia. Results: Among the study population, 108 patients had DM, and 433 were non-DM patients. Patients with DM were more likely to present symptoms such as fever (50.48%), anorexia (19.51%), dry cough (47.96%), shortness of breath (35.29%), chest pain (16.49%), and other symptoms. There was a significant decrease in the mean of haematological and biochemical parameters, such as haemoglobin, calcium, and alkaline phosphate in people with diabetes compared to non-diabetics and a considerable increase in other parameters, such as glucose, potassium, and cardiac troponin. Conclusions: According to the findings of this study, patients who have diabetes have a greater risk of developing more severe symptoms associated with COVID-19 disease. This could result in more patients being admitted to the intensive care unit as well as higher mortality rates.

Keywords